Preteens and teenagers with Type 1 diabetes have more trouble sticking to their treatment plan — thus raising their risk of blindness, kidney failure and heart disease — if their parents…

The official U.S. guideline that patients with diabetes should receive treatment to a blood pressure target of less than 130/80 mm Hg became suspect following reports from a pair of large studies showing no benefit in these patients beyond a goal systolic pressure of less than 140 mm Hg….

Pioglitazone and insulin together allow greater glycemic control, plus other advantages, in Type 2 diabetics, researchers have found….

Fasting plasma glucose levels within the normoglycemic range in childhood can be a predictor of prediabetes and Type 2 diabetes in adulthood, according to the results of a new study….

This week, the diabetes news included everything from the simple to the complex. On the simple side there were studies showing the value of food choices. Dr. Nancy F. Krebs, professor of pediatrics and head of the division of pediatric nutrition at the University of Colorado, completed a positive successful …

FDA Won’t Approve Statin-Fenofibrate Combo: The FDA said it won’t approve a new combo capsule for dyslipidemia until it learns more about the safety and efficacy of the compound, a decision that may be linked to the FDA’s review of the ACCORD trial findings.  AgaMatrix and sanofi-aventis sign a long-term …

The number of Americans living with diabetes and covered by Medicare will rise from 6.5 million to 14.1 million, and Medicare spending on diabetes will almost quadruple, skyrocketing from $45 billion this year to $171 billion in 2034. Health Affairs March 2010

The diabetes population in the U.S. will almost double over the next 25 years and annual medical spending on the disease is projected to hit $386 billion, up from $178 billion today. The number of Americans living with diabetes will rise from 23.7 million in 2009 to 44.1 million in …

Diabetes Screening Should Start Sooner: A recent study found that checking for blood sugar disease earlier cut complications and costs. Current recommendations suggest that screening for Type 2 diabetes start at age 45, especially for those who are overweight, but new research shows cost-effective screening can begin between the ages …

Screening for Type 2 diabetes is cost-effective when it’s initiated between ages 30 and 45 and continued every three to five years, researchers say.…